Novonix Discloses March 10 Director Share Sale in Form 6-K Filing

NOVONIX Ltd Sponsored ADR ( (NVX) ) just unveiled an announcement.

On March 12, 2026, Novonix Limited filed a Form 6-K with the U.S. Securities and Exchange Commission, notifying investors of a change in a director’s shareholding as required for foreign private issuers. The filing included an Appendix 3Y lodged with the ASX detailing that director Nicholas Liveris conducted an on‑market sale of 30,052 ordinary shares on March 10, 2026, for consideration of $9,194, reducing his direct holding from 589,142 to 559,090 shares, and confirming that the trade did not occur during a closed period, thereby signaling routine governance-driven disclosure rather than a structural shift in company strategy or control.

The most recent analyst rating on (NVX) stock is a Hold with a $0.81 price target. To see the full list of analyst forecasts on NOVONIX Ltd Sponsored ADR stock, see the NVX Stock Forecast page.

Spark’s Take on NVX Stock

According to Spark, TipRanks’ AI Analyst, NVX is a Neutral.

The score is primarily constrained by weak financial performance—deepening losses, severely negative margins, and accelerating cash burn—despite improving revenue. Technicals add modest support from a short-term move above the 20-day average, but the broader trend remains bearish. Valuation is also pressured due to negative earnings and no stated dividend yield.

To see Spark’s full report on NVX stock, click here.

More about NOVONIX Ltd Sponsored ADR

Novonix Limited is an Australia-based company whose securities trade in the U.S. via sponsored ADRs and are listed on the ASX. The company operates within the advanced materials and battery technology value chain, and, as a foreign private issuer, reports to the U.S. Securities and Exchange Commission under Form 20-F requirements.

Average Trading Volume: 1,091,832

Technical Sentiment Signal: Sell

Current Market Cap: $187.9M

See more data about NVX stock on TipRanks’ Stock Analysis page.